MAGS Roundhill Magnificent Seven ETF

Expense Ratio
0.29%
Dividend
1.68%
Previous close
$58.27
Est. 12 months change
+34.62%
Projected Price
$78.44

Profitability Metrics

Return on Equity (ROE)
52.46%
Return on Assets (ROA)
18.29%
Return on Invested Capital (ROIC)
45.73%
Weighted Average Cost of Capital (WACC)
12.01%
ROIC - WACC
33.72%
Updated : 2026-04-03 16:07 ET

Valuation Metrics

P/E Ratio
32.43
Forward P/E
26.65
PEG Ratio
1.80
Debt Current Ratio
2.00

Growth & Cash Flow

Gross Margin
56.95%
Operating Margin
32.93%
FCF Margin
21.02%
TTM Revenue Growth
22.09%
Projected 12M EPS Growth
21.70%

Price Change

Price % from 50 SMA
-5.70%
Price % from 200 SMA
-6.60%
6 Months
-10.34%
1 Year
23.51%
2 Years
49.91%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
MSFT18.36%
META15.50%
TSLA15.42%
AMZN14.18%
NVDA13.75%
AAPL13.29%
GOOGL9.51%

ETF Analysis

Fund Overview

Roundhill Magnificent Seven ETF (MAGS) currently reports 7 stock positions (subject to change), placing it in the concentrated range by holdings breadth. The top line-up is MSFT (18.36%), META (15.50%), TSLA (15.42%), with MSFT as the largest single weight at 18.36%. Together, the top three holdings account for 49.28%, which signals meaningful concentration at the top of the book, where a small number of names can drive outsized swings in fund performance. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.

Profitability & Capital Efficiency

From a capital efficiency perspective, ROIC is 45.73%, WACC is 12.01%, and the economic spread is 33.72%. On balance, the portfolio's holdings exhibit an exceptional economic spread, compounding intrinsic value at a rate few funds can match. Supporting metrics show ROE at 52.46% and ROA at 18.29%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Multiple analysis puts the portfolio at trailing P/E of 32.43, forward P/E of 26.65, PEG of 1.80. Trailing P/E sits modestly above forward P/E, a spread that is consistent with steady earnings progress and limited near-term re-rating potential. On a PEG basis, valuation is in the middle ground — fair for the growth on offer, with the return case resting on earnings delivery rather than re-rating. At 2.00, the aggregate current ratio indicates adequate but not exceptional balance sheet coverage. The combined valuation and liquidity profile points to a portfolio where current prices embed meaningful growth expectations, and where delivery against those expectations will drive the return outcome.

Margins & Cash Generation

On the margin front: gross margin sits at 56.95%, operating margin at 32.93%, and free cash flow margin at 21.02%. At this level, the portfolio reflects reasonable cost discipline and adequate pricing leverage at the production layer. The operating margin here is a standout — reflecting businesses that convert a large share of gross profit into operating earnings. Strong free cash flow margins point to businesses with meaningful financial flexibility and limited dependence on external capital. The margin trifecta here — strong at gross, operating, and free cash flow levels — is a hallmark of competitively advantaged businesses.

Growth & Forward Outlook

The two main inputs to the near-term picture — TTM revenue growth of 22.09% reflecting robust top-line expansion across the underlying holdings. Consensus EPS estimates point to 21.7% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations point to meaningful upside if execution holds on a 12-month view. Revenue momentum establishes the baseline; analyst price targets reveal how much the market is already paying for future execution on top of that baseline. Delivered returns will ultimately be shaped by the gap — or lack thereof — between operating execution and the expectations embedded in current prices. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Across the metrics reviewed, the evidence is consistently constructive — quality, growth, and valuation are pulling in the same direction.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.